Elena Nikulina

NeuroPace Inc revenue rises to 22.1 million as RNS System delivers 20 percent YoY growth

NeuroPace Inc revenue rises to 22.1 million as RNS System delivers 20 percent YoY growth
NeuroPace Inc lifts guidance

NeuroPace Inc reported revenue of 22.1 million for the first quarter of 2026, driven by approximately 20 percent year over year growth in its RNS System segment.

The company also raised its full year guidance, citing strong operating leverage and continued momentum across market, clinical, and product development. NeuroPace Inc indicated a clear roadmap ahead, along with plans for a webcast to discuss full results.

NeuroPace has recently highlighted life changing outcomes from a three-year post approval study of its RNS System. The company has also hosted a free webinar for epilepsy patients offering a live Q&A on the RNS System treatment. Both initiatives follow ongoing product and clinical development efforts.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.